đź“‹ FDA Reference

penumbra system reperfusion catheter red 72

Penumbra

Summary: The Penumbra System Reperfusion Catheter RED 72 is a medical device used for mechanical thrombectomy in venous systems. It is primarily used by interventional radiologists and vascular specialists to remove blood clots.

FDA Clearance Information

Pathway 510K
Decision Date February 13, 2025
Product Code NRY
Device Class Class 2
Evidence 15 studies

The Penumbra System Reperfusion Catheter RED 72 was cleared through the FDA 510(k) pathway on February 13, 2025. Manufactured by Penumbra, it is classified as a Class 2 device under product code NRY.

What It Is

The Penumbra System Reperfusion Catheter RED 72 is a specialized catheter designed for mechanical thrombectomy procedures. It works by navigating through the venous system to reach and remove thrombi, or blood clots, using suction or other mechanical means. This device is part of a broader system aimed at restoring blood flow in patients with venous thromboembolism.

Clinical Applications

This device is commonly used in the treatment of acute venous thromboembolism, including conditions like deep vein thrombosis and pulmonary embolism. It is typically utilized in hospital settings, particularly in interventional radiology suites or catheterization labs. The primary users are interventional radiologists and vascular surgeons who manage patients with acute or chronic venous occlusions.

Indications for Use

The FDA indications suggest that this device is intended for patients with venous thromboembolic events, such as those experiencing pulmonary embolism or deep vein thrombosis. It is designed to mechanically remove clots from the venous system to restore normal blood flow.

Practical Considerations

The Penumbra System Reperfusion Catheter RED 72 is available in various sizes to accommodate different patient anatomies and clot burdens. It is compatible with standard guidewires and introducer sheaths. Clinicians should be familiar with catheter navigation techniques and the potential need for adjunctive imaging.

Related Literature

The linked study compared systemic thrombolysis with catheter-directed management for acute intermediate-high risk pulmonary embolism. Although specific details are not available, such studies typically evaluate the efficacy and safety of catheter-based interventions versus systemic drug therapy. Limitations may include sample size and the lack of long-term outcome data.

Linked Studies (15)

PubMed • 2026

First-Pass Effect With Aspiration Thrombectomy With the Penumbra System in Patients With Acute Ischemic Stroke: A Core Laboratory-Adjudicated Subset Analysis of the COMPLETE Registry.

Stroke (Hoboken, N.J.)

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2023

Aspiration thrombectomy with the Penumbra System for patients with stroke and late onset to treatment: a subset analysis of the COMPLETE registry.

Frontiers in neurology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2022

Endovascular Treatment of Acute Ischemic Stroke With the Penumbra System in Routine Practice: COMPLETE Registry Results.

Stroke

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2019

Efficacy of a coaxial system with a compliant balloon catheter for navigation of the Penumbra reperfusion catheter in tortuous arteries: technique and case experience.

Journal of neurosurgery

View Source →
PubMed • 2018

Unilateral Acute Renal Artery Embolism: An Index Case of Successful Mechanical Aspiration Thrombectomy With Use of Penumbra Indigo Aspiration System and a Review of the Literature.

Vascular and endovascular surgery

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2017

Efficiency of the Penumbra 5MAX ACE Reperfusion Catheter in Acute Ischemic Stroke Patients.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2015

Mechanical thrombectomy with the penumbra 3D separator and lesional aspiration: technical feasibility and clinical outcome.

Clinical neuroradiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2015

Cerebral Venous Sinus Thrombosis: Successful Treatment of Two Patients Using the Penumbra System and Review of Endovascular Approaches.

The neuroradiology journal

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2012

Rescue forced-suction thrombectomy using the reperfusion catheter of the Penumbra System for thromboembolism during coil embolization of ruptured cerebral aneurysms.

Neurosurgery

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2012

The Penumbra system for mechanical thrombectomy in endovascular acute ischemic stroke therapy.

Neurology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2011

Direct thrombus retrieval using the reperfusion catheter of the penumbra system: forced-suction thrombectomy in acute ischemic stroke.

AJNR. American journal of neuroradiology

RCT|prospective|retrospective|case Series|other View Source →
ClinicalTrials.gov

COMPLETE: International Acute Ischemic Stroke Registry With the Penumbra System Aspiration Including the 3D Revascularization Device

View Source →
ClinicalTrials.gov

A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke

View Source →
ClinicalTrials.gov

European Registry on the ACE Reperfusion Catheters and the Penumbra System in the Treatment of Acute Ischemic Stroke

View Source →
ClinicalTrials.gov

LOTUS: Global Acute Stroke Study Utilizing Penumbra System

View Source →

Frequently Asked Questions

What is the Penumbra System Reperfusion Catheter RED 72 used for?

It is used for mechanical thrombectomy in the venous system to remove blood clots.

What specialties typically use this device?

Interventional radiologists and vascular surgeons typically use this device.

What are the FDA-cleared indications?

The device is indicated for the removal of thrombi in patients with venous thromboembolism, such as pulmonary embolism and deep vein thrombosis.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.